View our recent IND Enabling Services case study of an 11 months timeline to IND ready. Learn about our API process development and drug product formulation alongside both non-GMP and GMP production activities, and the final CTD documents.

Key Highlights

• Breakthrough Efficiency: Achieve IND readiness in 11 months, faster than industry standards for complex programs.
• Seamless Integration: Parallel workflows for API, DP, and CMC eliminate delays while ensuring compliance.
• End-to-End Expertise: From early-stage synthesis to CTD submission, all under one quality system.

BioDuro' s strategic model overcomes traditional development hurdles, enabling faster candidate progression and decisive go/no-go decisions.

Download the full case study to transform your IND strategy with expertise in accelerated drug development.